小剂量长春瑞滨抗血管生成化疗的实验研究

万莉

您当前的位置：

首页 >

文章列表页 >

小剂量长春瑞滨抗血管生成化疗的实验研究

2024神经精神疾病的治疗 | 更新时间：2023-12-18

- 小剂量长春瑞滨抗血管生成化疗的实验研究
- Experimental study of low doses of Vinorelbine in inhibiting angiogenesis
- 重庆医科大学学报 2012年37卷第5期页码：434-437
- 作者机构：
  
  东南大学医学院附属南京市第二医院肿瘤科,南京,210003
- 作者简介：
- 基金信息：
- DOI：
  中图分类号：
- 纸质出版日期：2012，
扫描看全文
万莉. 小剂量长春瑞滨抗血管生成化疗的实验研究[J]. 重庆医科大学学报, 2012,37(5):434-437.

WAN Li. Experimental study of low doses of Vinorelbine in inhibiting angiogenesis[J]. Journal of Chongqing Medical University, 2012,37(5):434-437.
万莉. 小剂量长春瑞滨抗血管生成化疗的实验研究[J]. 重庆医科大学学报, 2012,37(5):434-437. DOI：

WAN Li. Experimental study of low doses of Vinorelbine in inhibiting angiogenesis[J]. Journal of Chongqing Medical University, 2012,37(5):434-437. DOI：

摘要

目的：探讨长春瑞滨在体内外的抗血管生成活性及其可能的作用机制。方法：〖HTSS〗以人肺腺癌A549细胞为对照，采用MTT法、Transwell小室趋化实验、体外小管形成实验及流式细胞术（Flow cytometry

FCM），观察长春瑞滨对人脐静脉内皮细胞（Human umbilical vein endothelia cell

HUVEC）细胞增殖、迁移、形成毛细网管样结构的能力及细胞凋亡的影响；利用鸡胚绒毛尿囊膜（Chicken chorioallantoic membrane

CAM）模型，观察长春瑞滨对体内CAM新生血管的抑制作用。〖HTK〗结果：〖HTSS〗小剂量（0.1～1.0 ng/ml）长春瑞滨作用48 h，对HUVEC和A549细胞增殖抑制具有差异细胞毒作用（P=0.000）。0.1～0.8 ng/ml长春瑞滨对HUVEC作用12 h的迁移抑制率在20.56%～57.87%之间，与对照组相比，细胞迁移数明显减少（P<0.05

F=72.979

P=0.000）。0.1～0.8 ng/ml长春瑞滨对HUVEC作用24 h的小管形成抑制率在29.07%～56.83%之间，与对照组相比，小管形成数目明显减少且管腔结构趋于不完整，差异具有统计学意义（P<0.05

F=75.794

P=0.000）。0.1～0.8 ng/ml长春瑞滨作用48 h，诱导HUVEC细胞凋亡率在22.30%～37.05%之间，高于对照组细胞凋亡率15.60%（P<0.05；注：与对照组相比，在0.1、0.4、0.8 ng/ml长春瑞滨组的相应P=0.036、P=0.013、P=0.012）。体内实验显示，0.1～0.8 ng/ml长春瑞滨能够抑制CAM新生血管形成，抑制率在21.05%～42.11%之间，且抑制作用随药物浓度增加而增强。结论：①小剂量长春瑞滨在体外具有抑制血管内皮细胞增殖、迁移、小管形成及诱导细胞凋亡的作用。②小剂量长春瑞滨在体内具有抑制CAM血管形成的作用。

Abstract

Objective:To investigate the antiangiogenic ability and mechanism of Vinorelbine in vitro and in vivo. Methods: In vitro

MTT colorimetric assay was used to observe the effect of Vinorelbine on the proliferation of human umbilical vein endothelial cell (HUVEC) and human pulmonary adenocarcinoma A549 cells. Transwell cabin test and out body canaliculization test were used to observe the impact of Vinorelbine on cell migration and capillary like tube formation ability

and the apoptosis rate of HUVEC was calculated by flow cytometry (FCM). In vivo

the chicken chorioallantoic membrane (CAM) model was used to check whether the neovascularization of CAM could be suppressed. Results: Low dose Vinorelbine (0.1～1.0 ng/ml) could inhibit the proliferation of A549 and HUVEC after 48 h treatment

and the inhibition had significant differences (P=0.000). The number of migrating HUVEC was decreased as compared with that in the control group (P<0.05

F=72.979

P=0.000)

and the inhibition rate of migration was between 20/56%~40.40% when treated with 0.1~0.8 ng/ml Vinorelbine for 12 h. The number of tubules was reduced and the lumen lost its integrity as compared with that in the control group (P<0.05

F=75.794

P=0.000)

and the inhibition rate of tube formation was between 29.07%~56.83% when treated with 0.1~0.8 ng/ml Vinorelbine for 24 h. When HUVEC was incubated with 0.1~0.8 ng/ml Vinorelbine for 48 h

the apoptosis rate was between 22.30%~37.05%. At the same time

the apoptosis rate was higher than that of 15.60% in the control group (P<0.05); Note: compared with that of the control

P value for 0.1

0.4 ng/ml

and 0.8 ng/ml Vinorelbine was P=0.036

P=0.013

and P=0.012 respectively). We also observed that Vinorelbine

at concentrations of 0.1

0.4 ng/ml

and 0.8ng/ml

suppressed the neovascularization of CAM in vivo

and the inhibition rate was between 21.05%~42.11%. Moreover

the inhibition rate was enhanced as the drug concentration increased. Conclusion: ① In vitro

low dose Vinorelbine can inhibit the cell proliferation

migration

and tube formation of HUVEC

and has the ability of inducing apoptosis of HUVEC. ② In vivo

low dose Vinorelbine demonstrates antiangiogenic ability of CAM.

关键词

长春瑞滨人脐静脉内皮细胞Transwell流式细胞术鸡胚绒毛尿囊膜抗血管生成

Keywords

Vinorelbinehuman umbilical vein endothelial cells(HUVEC)Transwellflow cytometry(FCM)chorioallantoic membrane(CAM)antiangiogenic

references

浏览量

1153

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据